CLINICAL TRIAL: REGIMENS/TREATMENT SWITCHING STRATEGIES IN HIV CHILDREN ACTG390

临床试验：艾滋病毒儿童的治疗方案/治疗转换策略 ACTG390

• 批准号: 7950782
• 负责人: Sharon A Nachman
• 金额: $ 0.19万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950782
• 关键词: Anti-HIV Agents; Blood Circulation; Child; Clinical Research; Clinical Treatment; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; HIV; Institution; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Viral Load result

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG390 This study will evaluate two different treatment combinations of anti-HIV drugs and will use one of two plans for switching from one to the other treatment combinations. One plan will switch treatment combination when the amount of HIV in the bloodstream (viral load) is 1,000 copies and the other plan will switch treatment when the amount of HIV in the bloodstream is 30,000 copies. The study will evaluate if there is a difference in benefit for either of the two switching plans in a four year treatment.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 中心，不一定是研究者的机构。 ACTG390 这项研究将评估抗 HIV 药物的两种不同治疗组合，并将使用两种计划之一从一种治疗组合切换到另一种治疗组合。一个计划将在血液中的 HIV 数量（病毒载量）达到 1,000 份时转换治疗组合，而另一个计划将在血液中的 HIV 数量达到 30,000 份时转换治疗组合。该研究将评估在四年的治疗中两种转换计划中的任何一种的益处是否存在差异。